While Mylan and Pfizer’s Viatris Builds Its Leadership Team
• By Akriti Seth
Endo has named a new CEO and CFO, while Mylan and Pfizer’s Viatris has found its CFO and announced its full roster of board members. Meanwhile, Assogenerici names the leaders of its value added medicines sector group, law firm Fish & Richardson gets a new CEO and France appoints a new health minister.
Endo, Viatris and Siegfried get new board members • Source: Shutterstock
Endo International has named Blaise Coleman to succeed Paul Campanelli as the firm’s president and CEO.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
